February 13, 2014 | Illumina is creating a genomics-focused accelerator at its Mission Bay R&D facility under construction in San Francisco. The company plans to fully-equip lab space with Illumina machines and will invest $100,000 in each tenant company in exchange for 10% of common stock. Xconomy